Pharma Giant Merck To Acquire EyeBio For USD 3 Billion

Merck, a pharmaceutical firm, and Eyebiotech Limited (EyeBio), ophthalmology-centered biotechnology organization, reported that the organizations have gone into a conclusive arrangement under which Merck, through a subsidiary, will acquire...

BerGenBio Forays Clinical trial Pact with UT Health San Antonio and Sobi

A clinical trial agreement has been reached between Swedish Orphan Biovitrum AB (Sobi), a specialized international biopharmaceutical company, and the Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health...

Asahi Kasei To Acquire Calliditas Therapeutics For SEK 11.8 Billion

Asahi Kasei Corp. declares that Asahi Kasei will acquire the shares of the drug organization Calliditas to make Calliditas an entirely owned subsidiary of Asahi Kasei through a deliberate delicate proposal for Calliditas. The Tender Offer will...

US FDA Nods Amgen's Biosimilar to AstraZeneca's Blood Disorder Treatment

The U.S. Food and Drug Administration sanctioned Amgen's Bkemv, the first biosimilar to AstraZeneca's intriguing blood problem treatment Soliris. Amgen's medication will be advertised under the name Bkemv. Biosimilars are close duplicates of...

AstraZeneca Pharma Net Profit Rises To Rs. 39.5 crore in Q4FY24

AstraZeneca Pharma India Ltd's net profit for the quarter ended March 31, 2024 has doubled to Rs. 39.48 crore, up from Rs. 17.27 crore in the same time last fiscal year. Total income increased 34% to Rs. 391.86 crore during the quarter, compared...

Breakthrough Achieved by Chinese Scientists in Developing Diabetes Cure

In a huge clinical achievement, Chinese researchers have effectively cured a patient's diabetes utilizing a groundbreaking cell therapy. This spearheading treatment was created by a group from Shanghai Changzheng Emergency clinic, the Centre for...

Oncocross and JW Pharma Expand Partnership To Develop Innovative New Drugs

Oncocross, a pharmaceutical firm, declared on May 22nd that it has consented to a joint exploration arrangement with JW Pharmaceutical to foster new medications in view of the AI platform. Under this agreement, the two organizations will join...

EMA Confirms Henlius & Organon’s Marketing Authorization App For Prolia

Shanghai Henlius Biotech, Inc., a global biopharmaceutical firm, and Organon reported that the European Medicines Agency (EMA) has approved the marketing authorization applications (MAAs) for HLX14, an experimental Prolia and Xgeva (denosumab)...

Novotech Signs MoU with New Zealand Clinical Research

Novotech Pty Ltd., the worldwide clinical contract research organization (CRO) that accomplices with biotech organizations to speed up the improvement of cutting edge and novel therapeutics at each stage, has marked a MoU with New Zealand Clinical...

West Pharmaceutical Services Expands Capabilities in Asia

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced it has relocated to a new office facility in Seoul and expanded its warehouse capacity. This is part of West's...

© 2024 India Pharma Outlook. All Rights Reserved.